Quotes 5-day view End-of-day quote Shanghai Stock Exchange
06/30/2022
07/01/2022
07/04/2022
07/05/2022
07/06/2022
Date
356.73
350.78
353.44
351.66
345.01
Last
2825453
1907806
2071383
2517818
2286795
Volume
+2.21%
-1.67%
+0.76%
-0.50%
-1.89%
Change
Estimated financial data (e) CNY USD
Sales 2022
9 494 M
1 415 M
1 415 M
Net income 2022
3 031 M
452 M
452 M
Net cash position 2022
8 984 M
1 339 M
1 339 M
P/E ratio 2022
69,1x
Yield 2022
0,41%
Sales 2023
11 103 M
1 655 M
1 655 M
Net income 2023
3 736 M
557 M
557 M
Net cash position 2023
10 540 M
1 571 M
1 571 M
P/E ratio 2023
56,1x
Yield 2023
0,50%
Capitalization
208 B
31 031 M
31 031 M
EV / Sales 2022
21,0x
EV / Sales 2023
17,8x
Nbr of Employees
2 591
Free-Float
38,1%
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL.LTD is a China-based company principally engaged in pharmaceutical production and distribution business. The Company's major products include Pientzehuang series for pain-inhibition, anti-inflammation, detoxification and curing hepatitis, tablets for coronary heart diseases and hypertension, bupleurum granules for cold, as well as pharmaceuticals for bone injuries and others....
Ratings of Zhangzhou Pientzehuang Pharmaceutical., Ltd
All news about ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD
04/22 Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the First Quar.. CI
04/15 Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Full Year .. CI
2021 Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Nine Month.. CI
2021 MARKET CHATTER : Century-Old Chinese Companies Tap Into Stock Market to Fuel GrowthMT
2021 Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Half Year .. CI
2021 Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the First Quar.. CI
2021 EXCLUSIVE : Sinopharm-led consortium plans $3.3 billion take-private of HK-listed China TC..RE
2020 Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Nine Month.. CI
2020 China stocks end lower as high-flying consumer shares retreat RE
2020 Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Half Year .. CI
2020 Zhangzhou Pientzehuang Pharmaceutical., Ltd Approves Proposal of Investing in Newly Est.. CI
2020 Longhui Pharmaceutical Co., Ltd. announced that it expects to receive CNY 44.4759 milli.. CI
2020 Zhangzhou Pientzehuang Pharmaceutical., Ltd agreed to acquire 29.2% stake in Longhui Ph.. CI
2020 Zhangzhou Pientzehuang Pharmaceutical., Ltd Announces Cash Dividend Per A Share for the.. CI
2020 Zhangzhou Pientzehuang Pharmaceutical., Ltd Reports Earnings Results for the Full Year .. CI
News in other languages on ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD
Chart ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD
Short Term Mid-Term Long Term Trends Bullish Bearish Bearish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
7
Last Close Price
345,01 CNY
Average target price
356,76 CNY
Spread / Average Target
3,41%
Please enable JavaScript in your browser's settings to use dynamic charts.